Pharmaceutical giants Johnson & Johnson and Sanofi have stopped a late-stage clinical trial for their experimental E.coli ...

Even casual or low-earning side hustles may need business insurance to protect themselves, their customers, and their ...

NEW YORK — Fergie L. Philippe first saw the stage musical “Beauty and the Beast” pretty late, as a freshman in college. Kyra ...

Two Daytona 500 starting spots will be awarded to the highest open finishers in each qualifier. In the first race, the open ...

Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by ...

Johnson & Johnson said on Thursday it will discontinue a late-stage study of an experimental E.coli vaccine it was developing ...

Sanofi and Johnson & Johnson ended development of an experimental vaccine after it failed to adequately protect against an ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other Kevin O’Leary’s stock picks for 2025. Television personality, financier, and ...

Analysts cite Stelara exclusivity loss and MedTech competition as key challenges for Johnson & Johnson. Price target revisions: Tim Anderson lowers J&J forecast from $160 to $159. Brand New ...

LAKE FOREST, Ill. -- In the aftermath of the Detroit Lions' loss in the divisional round of the NFC playoffs, it didn't take long for Ben Johnson to realize where he wanted to continue his career.

Good morning and welcome to Johnson & Johnson's Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode until the question-and-answer session of the conference.